Ann: Appendix 4D and Half Year Report, page-56

First 56 Last

Share
Profile

Follow
Eaglebird

482 Posts.

5

04/03/18

23:15

Post #: 31518004
Share

Originally posted by eshmun ↑

Thanks @Cyberguy

You get what I'm saying. You should be able to weight your portfolio of gold stocks within the following three broad classes (from least weighting to most); explorer, developer, miner. When a miner's risk ends up being the same as an explore it's not an investment its a speculation. I put my big money into miners and the rest is spread between developers and explores. You can't put big money into DRM because it could quite easily turn into a BDR or TRY. It's no longer an investment it's a speculation with just as much downside (if not more) than some explorers. The constant pressure from trade creditors and debt providers in these type of (turnaround) stocks make them more risky than some cashed up explorers with practically zero EV like CHN. DRM is in its own class. Failed developer for now. It needs to claw its way out of that class into the miner category.

If the actual clown in this debate would stick to answering the two questions I asked in my post they might understand the value in owning DRM. Esh

Expand

Good posts with good info on both sides - thank you both.

Now can you blokes/gals please just call a truce re the debate.

I call it a draw and lets hope both DRM and CHN go up.

DRM Price at posting: 26.0¢ Sentiment: Hold Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

NVA

Nova Minerals achieves key milestone on path to Alaskan antimony production

CVL

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

IMR

Imricor Med and Philips launch commercial iMR lab solution

TGN

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

AS2

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

4DX

4DMedical posts FY26 revenue growth as commercial deployment ramps up

MEM

Memphasys receives early Thai FDA Felix approval

D3E

D3 Energy detects gas in South African helium hunt well

SEN

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

First 56 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Ann: Appendix 4D and Half Year Report, page-56

Top Stories

Nova Minerals achieves key milestone on path to Alaskan antimony production

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

Imricor Med and Philips launch commercial iMR lab solution

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

4DMedical posts FY26 revenue growth as commercial deployment ramps up

Memphasys receives early Thai FDA Felix approval

D3 Energy detects gas in South African helium hunt well

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

Featured News